Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer

BACKGROUND: PREDICT (http://www.predict.nhs.uk) is a prognostication and treatment benefit tool for early breast cancer (EBC). The aim of this study was to incorporate the prognostic effect of KI67 status in a new version (v3), and compare performance with the Predict model that includes HER2 status...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Wishart, Gordon C, Rakha, Emad, Green, Andrew, Ellis, Ian, Ali, Hamid Raza, Provenzano, Elena, Blows, Fiona M, Caldas, Carlos, Pharoah, Paul DP
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265394/
https://ncbi.nlm.nih.gov/pubmed/25472026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-908
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky